Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Harnessing catalytic knowledge to guide enzyme discovery and evolution with AlphaEnzyme

Created on 06 Nov 2026

Authors

Liu, Y., Zheng, S.

Abstract

Retrieving an enzyme for a target reaction provides a starting point for evolution, but predicting how to improve it remains difficult. This requires connecting evolutionary information with the structural and chemical context of catalysis. Here we present AlphaEnzyme, an enzyme foundation model built on a structure-grounded representation of an enzyme paired with its reaction, from which catalytic compatibility, kinetics and mutational response are read out together. On a time-separated benchmark, AlphaEnzyme achieves a top-1 catalyst retrieval success rate of 30.1%, against 17.2% for the strongest baseline. Michaelis constant predictions achieve the highest rank correlations among the compared methods, reaching 0.64 for enzymes sharing at most 40% identity with the kinetic training set. The model also enriches high-fitness TrpB variants at a budget of 16 candidates without target-specific fitness training. In prospective transaminase engineering, several prioritized variants exceed the parent, with the best design yielding a 30.4-fold increase in product signal in a lysate-based assay while retaining (R)-selectivity. Together, AlphaEnzyme provides a common molecular basis for selecting starting enzymes and prioritizing sequence changes for their improvement.

Preprint server: bioRxiv
The authors list and abstract were imported from bioRxiv on 06 Nov 2026.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this preprint? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 14
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement